225 related articles for article (PubMed ID: 20429905)
1. Mutations at opposite ends of the DIII/S4-S5 linker of sodium channel Na V 1.7 produce distinct pain disorders.
Cheng X; Dib-Hajj SD; Tyrrell L; Wright DA; Fischer TZ; Waxman SG
Mol Pain; 2010 Apr; 6():24. PubMed ID: 20429905
[TBL] [Abstract][Full Text] [Related]
2. NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders.
Estacion M; Dib-Hajj SD; Benke PJ; Te Morsche RH; Eastman EM; Macala LJ; Drenth JP; Waxman SG
J Neurosci; 2008 Oct; 28(43):11079-88. PubMed ID: 18945915
[TBL] [Abstract][Full Text] [Related]
3. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
4. Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation.
Jarecki BW; Sheets PL; Jackson JO; Cummins TR
J Physiol; 2008 Sep; 586(17):4137-53. PubMed ID: 18599537
[TBL] [Abstract][Full Text] [Related]
5. Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.
Eberhardt M; Nakajima J; Klinger AB; Neacsu C; Hühne K; O'Reilly AO; Kist AM; Lampe AK; Fischer K; Gibson J; Nau C; Winterpacht A; Lampert A
J Biol Chem; 2014 Jan; 289(4):1971-80. PubMed ID: 24311784
[TBL] [Abstract][Full Text] [Related]
6. Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7.
Estacion M; Han C; Choi JS; Hoeijmakers JG; Lauria G; Drenth JP; Gerrits MM; Dib-Hajj SD; Faber CG; Merkies IS; Waxman SG
Mol Pain; 2011 Dec; 7():92. PubMed ID: 22136189
[TBL] [Abstract][Full Text] [Related]
7. Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons.
Harty TP; Dib-Hajj SD; Tyrrell L; Blackman R; Hisama FM; Rose JB; Waxman SG
J Neurosci; 2006 Nov; 26(48):12566-75. PubMed ID: 17135418
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of Na(V)1.7 exon 5 increases the impact of the painful PEPD mutant channel I1461T.
Jarecki BW; Sheets PL; Xiao Y; Jackson JO; Cummins TR
Channels (Austin); 2009; 3(4):259-67. PubMed ID: 19633428
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.
Dib-Hajj SD; Estacion M; Jarecki BW; Tyrrell L; Fischer TZ; Lawden M; Cummins TR; Waxman SG
Mol Pain; 2008 Sep; 4():37. PubMed ID: 18803825
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for severe pain caused by mutations in the S4-S5 linkers of voltage-gated sodium channel Na
Wisedchaisri G; Gamal El-Din TM; Zheng N; Catterall WA
Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2219624120. PubMed ID: 36996107
[TBL] [Abstract][Full Text] [Related]
11. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade.
Cheng X; Dib-Hajj SD; Tyrrell L; Waxman SG
Mol Pain; 2008 Jan; 4():1. PubMed ID: 18171466
[TBL] [Abstract][Full Text] [Related]
12. Size matters: Erythromelalgia mutation S241T in Nav1.7 alters channel gating.
Lampert A; Dib-Hajj SD; Tyrrell L; Waxman SG
J Biol Chem; 2006 Nov; 281(47):36029-35. PubMed ID: 17008310
[TBL] [Abstract][Full Text] [Related]
13. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.
Han C; Yang Y; de Greef BT; Hoeijmakers JG; Gerrits MM; Verhamme C; Qu J; Lauria G; Merkies IS; Faber CG; Dib-Hajj SD; Waxman SG
Neuromolecular Med; 2015 Jun; 17(2):158-69. PubMed ID: 25791876
[TBL] [Abstract][Full Text] [Related]
14. I
Vasylyev DV; Liu S; Waxman SG
J Physiol; 2023 Dec; 601(23):5341-5366. PubMed ID: 37846879
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear effects of hyperpolarizing shifts in activation of mutant Na
Estacion M; Waxman SG
J Neurophysiol; 2017 Apr; 117(4):1702-1712. PubMed ID: 28148645
[TBL] [Abstract][Full Text] [Related]
16. Erythromelalgia mutation L823R shifts activation and inactivation of threshold sodium channel Nav1.7 to hyperpolarized potentials.
Lampert A; Dib-Hajj SD; Eastman EM; Tyrrell L; Lin Z; Yang Y; Waxman SG
Biochem Biophys Res Commun; 2009 Dec; 390(2):319-24. PubMed ID: 19800314
[TBL] [Abstract][Full Text] [Related]
17. Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes.
Dib-Hajj SD; Yang Y; Waxman SG
Adv Genet; 2008; 63():85-110. PubMed ID: 19185186
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide.
Theile JW; Cummins TR
Mol Pharmacol; 2011 Oct; 80(4):724-34. PubMed ID: 21788423
[TBL] [Abstract][Full Text] [Related]
19. Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin.
Rice FL; Albrecht PJ; Wymer JP; Black JA; Merkies IS; Faber CG; Waxman SG
Mol Pain; 2015 May; 11():26. PubMed ID: 25957174
[TBL] [Abstract][Full Text] [Related]
20. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
